This invention involves compounds having the following structure:
1
as described in the Claims; and enantiomers, optical isomers, stereoisomers, diastereomers, tautomers, addition salts, biohydrolyzable amides and esters thereof, as well as pharmaceutical compositions comprising such novel compounds. The invention also relates to the use of such compounds for preventing or treating disorders modulated by alpha-2 adrenoceptors.
本发明涉及具有以下结构的化合物:1如权利要求所述;以及其对映异构体、光学异构体、立体异构体、顺反异构体、互变异构体、加合物盐、
生物可
水解酰胺和酯,以及包含这些新型化合物的药物组合物。本发明还涉及使用这些化合物预防或治疗通过α-2
肾上腺素受体调节的疾病。